Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1293"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1773"
rdf:type	?:Evidence ?:Item
?:Evidence_enzyme_system	""
?:Evidence_type	?:Non_Tracable_Statement
?:content	"Fluvoxamine is listed as a recommended inhibitor of CYP1A2 for in vivo studies in Table 2 (p. 19). Typically, this would qualify it as a in vivo selective inhibitor however, Table 2 also shows fluvoxamine as a recommended inhibitor of 2C19."
dc:creator	"boycer"
dc:date	"05/05/2009 17:26:22"
rdfs:seeAlso	?:FDA-Guidance-Drug-Interaction-Studies%E2%80%93Study%20Design-Data-Analysis-and-Implications-2006.pdf

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ fluvoxamine_inhibits_cyp1a2, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1773 }

Context graph